Upgrade to SI Premium - Free Trial

H.C. Wainwright Starts Immunogen Inc. (IMGN) at Buy

January 31, 2018 7:19 AM
H.C. Wainwright initiates coverage on Immunogen Inc. (NASDAQ: IMGN) with a Buy rating and a price target of $18.00.Analyst Debjit ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Hot New Coverage New Coverage